Physician profile
Ken Hsu
NPI 1275695843
$1,363.92
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $320 · 2020: $282 · 2021: $45.57 · 2022: $513 · 2023: $163 · 2024: $40.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $203.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $846.79 | 2019-2023 | Core, N/A |
| Spineart USA INC | $251.11 | 2022-2023 | Perla Tl |
| Amgen INC. | $55.60 | 2020-2022 | |
| Titan Spine, LLC | $43.96 | 2019 | |
| Si-Bone, INC. | $38.92 | 2020-2024 | |
| Smith+Nephew, INC. | $26.32 | 2022 | |
| Relievant Medsystems, INC. | $23.75 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $21.42 | 2024 | |
| Orthofix Medical, INC. | $20.83 | 2023 | Galaxy Fixation Gemini, Galaxy Fixation System, Truelok |
| Baudax Bio INC. | $18.54 | 2021 | |
| Vertiflex, INC. | $16.68 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ken Hsu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.